Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|May 3, 2014
[Surgical treatment of giant congenital melanocytic nevi: a change of aim]J Carrera, A Albert, F J Parri, et al.
Journal of Inorganic Biochemistry|May 26, 2001
Structural characterization and cytostatic activity of chlorobischolylglycinatogold(III)J Carrasco, J J Criado, R I Macías, et al.
Revista Espanola De Enfermedades Digestivas|August 21, 2002
Lung changes and cytokine levels in a model of experimental acute pancreatitisG Mozo, M L del Olmo, A Caro-Patón, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2L Moltó, J Carballido, L Manzano, et al.
Revista Clinica Espanola|November 6, 2009
[Cardiac myxoma: an analysis of 30 patients]C García Zubiri, M Yebra Yebra, C Salas Antón, et al.
Hepato-Gastroenterology|December 2, 2000
Twelve-month interferon-alpha therapy induces a similar sustained response in anti-HBe-positive and HBeAg-positive chronic hepatitis B patientsI Fernández, G Castellano, M L Manzano, et al.
Gut|February 1, 1992
Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2L Manzano, M Alvarez-Mon, L Abreu, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patientsJ A Girón, M Alvarez-Mon, J L Menéndez-Caro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary siteC Balaña, J-L Manzano, I Moreno, et al.
British Journal of Cancer|December 1, 1994
Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activationL Molto, M Alvarez-Mon, J Carballido, et al.
Pageof 20